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Effect of hypertonic dialysate and vasodilators on peritoneal
dialysis clearances in the rat. A model for performing peritoneal
dialysis in the rat was established which permitted the consistent
measurement of dialysis clearances. The effects on urea and inulin
clearances of intraperitoneal vasodilators and 4.25% dextrose
were compared. Isoproterenol, nitroprusside, histamine, and
bradykinin, when added to 1.5% dextrose dialysate for three
consecutive exchanges, all produced approximately a 20%
increase in urea and inulin dialysis clearances. These increases in
clearances persisted in the three subsequent exchanges when no
drugs were added to the dialysate. The addition of isoproterenol,
nitroprusside, or histamine to six consecutive exchanges did not
produce a further increment in clearances. The use of 4.25%
dextrose dialysate for three exchanges produced approximately a
50% increase in urea and inulin clearances. Clearances remained
about 35% greater than control values in the subsequent three
1.5% dextrose exchanges.
Effet du dialysat hypertonique et des vasodilatateurs sur les
clearances de dialyse péritonéale chez le rat. Un modèle
d'execution de dialyse péritonéale chez le rat a été étudié qui
permet la mesure des clearances de La dialyse. Les effets, sur les
clearances de l'urée et de 1' inuline des vasodilatateurs intra-pénto-
néaux et du dextrose a 4,25% ont été compares. L'isoprotérénol,
le nitroprussiate, l'histamine, et la bradykinine ajoutés a du dialy-
sat contenant 1,5% de dextrose au cours de trois cycles consécu-
tifs, produisent chacun une augmentation d'environ 20% des clear-
ances de l'urée et de l'inuline. Ces augmentations persistent
pendant les trois cycles suivants alors que les drogues ne sont plus
ajoutées au dialysat. L'addition d'isoprotérénol, de nitroprussiate,
ou d'histamine au cours de six cycles consécutils ne produit pas
d'augmentation supplémentaire des clearances. L'emploi d'un
dialysat contenant 4,25% de dextrose pendant trois cycles consé-
cutifs produit une augmentation d'environ 50% des clearances de
l'urée et de l'inuline. Ces clearances demeurent supéneures
d'environ 35% aux valeurs contrôles au cours des trois cycles
suivants réalisés avec du dextrose a 1,5%.
Chronic peritoneal dialysis in patients with end-
stage renal disease requires approximately 36 hours a
week of dialysis therapy [1]. Recent attention has
been focused on finding ways to increase dialysis
efficiency and, thus, to decrease the time required
for peritoneal dialysis. It has been claimed that the
addition of vasodilators and surface active drugs to
dialysate fluid increases the efficiency of peritoneal
dialysis [2—7]. Furthermore, the use of hypertonic
dialysate has been shown to increase peritoneal
clearances [8, 9].
In the present study, a method of performing pen-
toneal dialysis in rats was established so that several
clearance periods could be studied over a relatively
short period of time in a reproducible fashion. Then,
alterations in small and middle molecule dialysis
clearances produced by the use of 4.25% dextrose
dialysate and the intraperitoneal administration of
several drugs were examined. The drugs studied
included two potent vasodilators, isoproterenol and
nitroprusside, which have been shown to increase
dialysis clearances in other studies [2, 3]. In addi-
tion, the effects of the vasodilators histamine and
bradykinin were examined since these drugs also
increase capillary permeability [101.
Previous investigators, examining the effects of
intraperitoneal vasodilators on dialysis clearances,
have only added the drugs to two or three consecu-
tive exchanges [2]. In the present study, we added
the drugs to three and six consecutive exchanges to
see if a more significant increase in clearances could
be produced with sustained intraperitoneal adminis-
tration of the vasodilators.
Methods
Male Sprague-Dawley rats weighing 250 to 350 g
were used. Under ether anesthesia, an external jugu-
lar vein was cannulated with PE-50 tubing, and a
loading dose of mactin® (Promanta, Hamburg), 80
mg/kg of body wt, was given i.v. over 5 mm. Then, a
tracheostomy was performed, and surgical losses
were replaced with an infusion of 0.15 M sodium
chloride in a volume equal to 1% of body wt. A
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priming dose of 25 jCi of methoxy-inulin 3H (New
England Nuclear Corp.) was administered, and a
constant i.v. infusion of 0.075 M sodium chloride,
containing 50 mglml of urea, 20 CiJm1 of inulin 3H,
and 20mg/kg of body wt per ml of mactin, was begun
at a rate of 1.2 mI/hr.
Commercially available, bottled, 1.5% dextrose
peritoneal dialysate (Travenol) of standard electro-
lyte composition was used and maintained at 37°C by
a constant temperature bath. A 14-gauge i.v. catheter
(Jelco) was placed percutaneously in the right lower
quadrant of the abdomen into the peritoneal cavity.
Twenty-five milliliters of dialysate was instilled into
the peritoneal cavity and then immediately allowed
to drain. This procedure was repeated at least three
times or until the drainage fluid was clear. Any rat in
which the bowel had been perforated or which had
persistent bleeding into the peritoneal cavity was
discarded; this occurred in approximately 5% of the
rats studied. Fifteen-minute exchanges were then
started. The volume of dialysate used was always 25
ml. Preliminary studies indicated that this volume of
dialysate was necessary to achieve consistent and
reproducible drainage volumes equivalent to the vol-
ume of dialysate instilled. All animals studied tolerat-
ed the instillation of the 25-ml volume without devel-
oping respiratory distress. The time required for
instillation of fluid into the peritoneal cavity with a
syringe was 15 seconds. The exchange then consist-
ed of 12 mm's dwell-time and 3 mm's drain-time. The
dialysate was allowed to drain by gravity into a Petri
dish; the drainage was assisted by applying light
manual pressure to the abdomen. The volume of the
drainage fluid was measured. Since dialysate drain-
age volumes during 4.25% dextrose exchanges were
significantly greater than 25 ml, the volume drained
in excess of 25 ml was replaced by the equivalent
volume of 0.15 M sodium chloride i.v. Dialysate
drainage volumes during clearance periods with
1.5% dextrose dialysate and vasodilators added were
not significantly different from the volume infused.
As in previously reported animal models Ui], we
found that clearances increased during the initial
exchanges. Preliminary studies indicated that clear-
ances remained constant after the first hour. There-
fore, four 15-mm exchanges were completed in each
animal before starting the experimental protocol. At
the start of each experimental exchange and at the
end of the last exchange, blood was collected from
the tail vein. Blood samples and aliquots of dialysate
drainage fluid were analyzed for inulin and urea
nitrogen concentrations. The concentration of 3H-
inulin was determined on a liquid scintillation count-
er (Packard Tri-Carb). Urea nitrogen concentrations
were measured on an autoanalyzer (Technicon).
Blood urea nitrogen concentrations remained 35 mg
to 50 mg/dl during the clearance studies.
Clearances (C) were calculated using the standard
formula [8]:
Cd X Vd/(Cbi + Cbe) x t
2
where Cd is the concentration of solute in dialysate
drainage fluid, Vd is the volume of dialys ate drainage
fluid, Cbi is the concentration of solute in plasma at
the beginning of the exchange, Cbe is the concentra-
tion of solute in the plasma at the end of the ex-
change, and t is the time of the exchange (15 mm).
Following four preliminary peritoneal exchanges,
eight consecutive clearance periods were performed
in each animal. In control animals, clearance was
measured when 1.5% dextrose dialysate was
exchanged. Then, the effects of vasodilators on peri-
toneal dialysis were studied. Exchanges 1 and 2
utilized 1.5% dextrose dialysate. During exchanges
3, 4, and 5, an experimental drug was added to the
1.5% dextrose dialysate. Exchanges 6, 7, and 8 again
utilized 1.5% dextrose dialysate alone. The drugs
tested in this study were added to dialysate in the
following concentrations: 12 pg/liter of isoproteren-
ol, 120 /Lglliter of sodium nitroprusside, 4 pg/liter of
histamine, 8 gIliter of histamine, and 3 /.Lg/liter of
bradykinin. Preliminary experiments indicated that
these arbitrarily selected dosages were associated
with increments in peritoneal dialysis clearances
similar to those that have been observed in patients
[2]. The mean clearance of exchanges 1 and 2 (period
I) was compared with the mean clearance of
exchanges 4 and 5 (period II) and the mean clearance
of exchanges 7 and 8 (period III). Exchanges 3 and 6
were regarded as washout exchanges. To determine
the effect of 4.25% dextrose dialysate on peritoneal
clearances, a similar protocol was employed. Fol-
lowing two baseline exchanges with 1.5% dextrose
dialysate (period I), 4.25% dextrose dialysate was
exchanged during period II, followed by 1.5% dex-
trose dialysate in period III.
To determine whether continuous i .p. instillation
of vasodilators further enhanced peritoneal clear-
ances, isoproterenol, sodium nitroprusside, and the
larger dose of histamine were instilled in six consecu-
tive exchanges in the concentrations noted above.
Exchanges 1 and 2 utilized 1.5% dextrose dialy sate
alone. The drug to be tested was then added to all
exchanges from 3 to 8. Clearances during period I
(exchanges 1 and 2), period II (exchanges 4 and 5),
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and period III (exchanges 7 and 8) were then
calculated.
Results
Control animals. In the control animals, urea and
inulin clearances remained constant throughout
periods I, II and III (Table 1). The dialysate drainage
volumes remained stable throughout, being 25.6
0.1 ml in period!, 25.0 0.4 ml in period II, and 25.0
0.1 ml in period II!. The mean coefficient of
variation for volume measurements in the control
animals was 4.9 1.1%, indicating that the volume
of dialysate drainage could be measured in a repro-
ducible fashion.
Use of vasodilators and 4.25% dextrose in
exchanges 3 through 5. A representative set of data
from one rat is shown in Table 2. The combined data
for the different agents studied is shown in Table 1.
The urea and inulin clearances during period II are
significantly higher than during period I by paried t
testing analysis for all agents studied. With 4.25%
dextrose and when isoproterenol, nitroprusside,
bradykinin, and 8 pgIliter of histamine were added to
the dialysate, the increase in urea and inulin clear-
ances observed in period I! persisted in period III.
When 4 gIliter of histamine was added to the dialy-
sate, however, urea and inulin clearances increased
significantly in period II! compared to period I!, even
though histamine was no longer being added to the
dialysate. The inulin to urea clearance ratio remained
constant throughout all periods studied with all
agents used except for bradykinin which resulted in a
small but statistically significant increase in clear-
ance ratios from periods Ito II, 0.32 0.02 to 0.36
0.03, P < 0.02 (Table 1).
With all the drugs tested, there was no significant
change in dialysate drainage volume, and hence, the
increase in clearance was due to an increase in the
urea and inulin dialysate to plasma concentration (DI
P) ratio alone. When 4.25% dextrose dialysate was
used, however, the volume of the dialysate drainage
volume increased significantly in period II from 25.5
0.6 to 27.9 0.4 ml, P < 0.05. The increase in
clearance, however, with 4.25% dextrose was not
due to the increase in volume alone, since the DIP
ratio for both urea and inulin also rose significantly
during period I! (Table 3).
The percent increase in clearances for the different
agents is shown in Figures 1 and 2. With 4.25%
dextrose dialysate, urea clearance increased 40
6%, and inulin clearance increased 52 5%. The
percent increase in both urea and inulin clearance
was approximately 20% with all of the drugs tested.
Use of vasodilators in exchanges 3 through 8. The
effect on urea and inulin clearances of adding isopro-
terenol, nitroprusside, or 8 sgI1iter of histamine to
six continuous exchanges is shown in Table 4. There
is no statistically significant difference in urea or
inulin clearances between period II and period III
with any of the drugs used.
Discussion
Peritoneal dialysis as maintenance therapy for
patients with end-stage renal disease requires
approximately 36 hours a week of dialysis duration
[1]. If the efficiency of the dialysis could be
increased, then perhaps the dialysis time could be
decreased. Theoretically, peritoneal dialysis clear-
ances are determined by blood flow to the peritoneal
surface, the presence or absence of ultrafiltration,
Table 1. Summary of the effects of 4.25% dextrose dialysate and vasodilators on peritoneal clearances
Experimental
procedure Pe
Ca, pJlmin C11, pi/min Cuiin/Ca
nod I Period II Period III Period I Period II Period III Penod I Period II Period III
Control
(N=6)
4.25% dextrose
(N=5)
Isoproterenol, 12 jsg 511 30 647 50 643 28 142 4 172 6 175 9 0.29 0.02 0.27 0.02 0.29 0.02
(N=8)
Nitroprusside, 120 g 452 32 520 241 560 2 152 6 178 41 176 41 0.34 0.01 0.34 0.01 0.32 0.01
(N=5)
Histamine, 4 ng
(N=5)
Histamine, 8 g
(TV= 6)
Bradykinin, 3 ng
(N=5)
a P <0.05 compared to Period I.
b p < 0.05 compared to Period II.
460 35 455 30 498 38 151 8 153 6 158 11 0.33 0.01 0.34 0.02 0.32 0.01
440 13 615 3G1 583 301 121 2 184 176 0.28 0.02 0.30 0.02 0.30 0.02
448 15 504 241 552 3' 151 5 165 181 12a.b 0.34 0.01 0.33 0.01 0.33 0.01
401 25 466 l5 495 2 136 9 157 16 160 41 0.33 0.03 0.34 0.01 0.32 0.01
452 29 510 2& 538 1 144 5 180 6 190 12 0.32 0.02 0.36 0.03 0.35 0.02
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dialysate flow rate, and the area, permeability, and
pore size of the peritoneal membrane. Previous stud-
ies have shown that increasing the dialysate flow rate
does increase clearances; dialysate flow rate, how-
ever, is limited by the time required for the inflow
and outflow of the dialysate [4]. The use of 7%
dextrose dialysate increases clearances by both
ultrafiltration and direct enhancement of solute
transfer [8, 9]. Seven percent dextrose dialysate,
however, may result in large fluid losses for the
patient, and it is no longer commercially available.
Current interest in increasing clearances has focused
on the use of drugs which alter the characteristics of
peritoneal transport by increasing peritoneal mem-
brane area, permeability, or blood flow.
Two groups of drugs have been studied—surface
active agents and vasodilators. Surface active agents
added to the dialysate increase clearances by a poor-
Table 2. Representative set of data in one rat
Exchanger' Drug
Volume
ml
Curea
p1/mm
C111
p1/mm
1 — 25.6 557 126
2 — 23.8 485 119
3 Isoproterenol 25.1 573 142
4 Isoproterenol 25.9 627 150
5 Isoproterenol 25.0 661 144
6 — 25.0 637 146
7 — 25.5 629 141
8 — 24.6 621 140
Period I = exchanges I and 2; period U = exchanges 4 and 5;
period III = exchanges 7 and 8.
ly understood mechanism. Trisaminomethane [5]
and dioctyl sodium sulfosuccinate [6] produce ap-
proximately a two-fold increase in urea clearances in
the dog. The use of these drugs, however, is limited
because of their toxicity, and therefore, they have
not been studied in patients. The addition of vasodi-
lators to the dialysate has been shown to increase
clearances in both animals and man. Nolph et al, for
example, studied the effects of five vasodilators
(phentolamine, hydralazine, isoproterenol, diazox-
ide, and nitroprusside) on urea and creatinine perito-
neal dialysis clearances in patients [2]. The drugs
were added to the dialysate in doses that would not
exceed amounts that could be given intravenously
over a time period equal to that of the exchange.
Drugs were only added to three consecutive
exchanges. Isoproterenol, diazoxide, and nitroprus-
side were found to increase clearances. Nitroprus-
side had the greatest effect and increased peritoneal
urea clearance by 17%. Mass transfer coefficients for
urea and inulin, calculated by their rate of appear-
ance in dialysate, also increased significantly when
nitroprusside was added to the dialysate [12]. Stud-
Table 3. Effect of using 4.25% dextrose dialysate on volume and
dialysate/plasma (D/P) concentration ratios.
Period I Period II Period III
Volume, ml 25.5 0.6 27.9 0.4 25.9 0.3k'
D/P urea 0.258 0.006 0.330 0.0l4 0.337 0.016
DIP inulin 0.072 0.002 0.099 0.002' 0.10 0.0v'
P <0.05 compared to Period I.
P <0.05 compared to Period 11.
Table 4. Effect on clearances of adding a drug to six consecutive
exchanges
Curea, i4lmin C1,,,,11, pgllmmn
Drug Period II Period Ill Period II Period III
Isoproterenol, 12 sg 605 14 582 24 145 8 150 7
(N =7)
Nitroprusside, 120 jg 565 45 606 39 218 13 227 11(N = 6)
Histamine, 8 g 489 21 523 16 200 11 208 12
(N =7)
Fig. 1. Percentage increases in urea clearance produced by the
addition of vasodilators or the use of 4.25% dextrose for three
exchanges.
C Control Bradykinin
4.25% Nitroprusside Histamine
dextrose B pg
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Control Isoproterenol Histamine
4 pg
4.25% Nitroprusside Histamine
dextrose 8 pg
B radykin in
Fig. 2. Percentage increases in mu/in clearance produced by the
addition of vasodilators or the use of 4.25% dextrose for three
exchanges.
ies in the dog have shown also that isoproterenol will
increase the mass transfer coefficients for urea and
creatinine if given intraperitoneally, but not if given
intravenously [7].
The present study was designed to establish a
model of peritoneal dialysis in the rat so that small
and middle molecule dialysis clearances could be
easily and reproducibly measured. While a previ-
ously described model of peritoneal dialysis in the rat
employed a surgically implanted catheter [ 13], we
found that a percutaneous puncture produced easy
access and reproducible results. Since inflow and
dialysate drainage time for this model is considerably
less than in patients, clearances of several successive
exchanges could be measured over a relatively short
period of time. In the control studies, employing
1.5% dextrose dialysate, the urea (mol wt, 60) and
inulin (mol wt, 5,200) clearances after the first four
exchanges were constant during the eight subsequent
experimental exchanges. Dialysate drainage volume
could be measured in a reproducible fashion since
the mean coefficient of variation of these measure-
ments in the control animals was 4.9 1.1%. The
effects on urea and inulin clearances of drugs added
intermittently or continuously to the dialysate there-
fore could be examined.
Isoproterenol, nitroprus side, histamine, and
bradykinin, when added to the dialysate, all in-
creased urea and inulin clearances by approximately
20%. This is about the same percentage increase in
urea clearance as produced by intraperitoneal nitro-
prusside in man [2] . The effect of bradykinin and
histamine on peritorieal clearances have not been
determined previously. Bradykinin has been shown
to be one of the most powerful mesenteric vasodila-
tors [ 14] . In addition to their vasodilatory properties,
bradykinin and histamine also both increase capillary
permeability [ 10] . In the present study, these drugs,
however, did not increase peritoneal clearance more
than did isoproterenol or nitroprusside.
During the three exchanges following drug instilla-
tion (period III), urea and inulin clearances remained
elevated; there were no significant differences in
clearances between periods II and III except when 4
1itg/liter of histamine was added to the dialysate.
Since it seemed important to determine whether fur-
ther increases in peritoneal dialysis clearances could
be produced by addition of vasodilators to more than
three exchanges, drugs were added to six consecu-
tive exchanges. Both inulin and urea clearances,
however, did not continue to rise with each ex-
change; the clearances for both urea and inulin were
not significantly different in the last two exchanges
with drugs added than in the initial exchanges (period
II). This suggests that, under the conditions of the
present study, the continuous use of vasodilators
may be no more efficient than the intermittent use of
drugs in enhancing peritoneal solute transfer.
During the use of 4.25% dextrose dialysate, urea
clearance increased by 40 6% and inulin clearance
by 52 5% . Unlike the vasodilators , 4.25% dextrose
increased the dialysate drainage volume, indicating
that ultraffitration was a major factor in increasing
clearances . Elevated clearances persisted, however,
during the subsequent three isotonic exchanges,
despite the fact that the dialysate drainage volume
had returned to the baseline value of 25 ml. Thus,
after the 4.25% dextrose dialysate exchanges, the
urea clearance remained 33 7%, and the inulin
clearance remained 45 7% greater than the control
clearances. This is in accordance with the studies of
Henderson and Nolph [9], who used 7% dextrose
dialysate in patients, and indicates that mechanisms
other than ultrafiltration must be involved in enhanc-
ing peritoneal dialysis clearances.
It should be noted that certain differences exist
between the kinetics of peritoneal dialysis performed
under the conditions of the present study and pre-
vious observations in man. Throughout the present
study, the ratio of inulin to urea clearances remained
50 -
40-
I
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constant and was not effected by the addition of
vasodilators or the use of 4.25% dextrose dialysate.
In contrast, the studies in patients using vasodilators
and hypertonic dialysate resulted in a proportionally
greater increase in inulin clearance than urea clear-
ance. A possible explanation for this discrepancy
involves the limitations placed upon increments in
urea clearances by the dialysate flow rate in the
patient studies. Thus, in the patient studies of Hen-
derson and Nolph [9] and Noiph et al [2], the rate of
dialysate flow, about 29 cc/mm, was less than twice
the urea clearance and, thus, may have been a criti-
cal factor limiting the percent increase in urea clear-
ance produced by modifications in therapy. On the
other hand, the dialysate flow rate in the present
study, about 1.7 cc/mm, was about 3 to 4 times as
great as the urea clearance and, thus, may have
permitted a more substantial fractional increment in
urea clearance. In addition, the present observations
indicate that during the three exchanges following
drug instillation, the urea and inulin clearances
remained significantly increased. In contrast, studies
in patients have not found a consistent residual
increase in clearances following the use of intraperi-
toneal vasodilators [2]. The reasons for these discre-
pant findings are not readily apparent.
The constant urea to inulin clearance ratio during
the addition of vasodilators to the dialysis fluid with
the relatively high dialysate flow rate suggests that
the increases in clearances produced by the drugs
may be due to an increase in effective surface area
for exchange of solutes rather than to alterations in
blood flow or membrane permeability [9]. Recent
studies looking at the microcirculation of rat cremas-
ter muscle bathed in peritoneal dialysis solution dem-
onstrated that when nitroprusside was added to the
dialysis fluid, continuous perfusion of previously
intermittently or non-perfused arterioles was estab-
lished [12]. Thus, nitroprusside apparently increases
the endothelial area available for peritoneal transfer
by increasing the total area of arterioles and capillar-
ies perfused. The constancy of the urea to inulin
clearance ratio in the present study supports this
hypothesis.
In conclusion, a method of performing peritoneal
dialysis in the rat has been established that permits
the study of several clearance periods over a brief
period of time. Approximately a 20% increase in
both urea and inulin dialysis clearances is produced
by the addition of vasodilators to 1.5% dextrose
dialysate for three exchanges. A further increment in
clearance does not result from the addition of vasodi-
lators to six consecutive exchanges. A more signffi-
cant increment in clearances, however, is produced
by the use of 4.25% dextrose dialysate for three
exchanges. This increment persists in the subsequent
exchanges using 1.5% dextrose dialysate. Thus, the
intermittent use of hypertonic dialysate may repre-
sent an efficient means of increasing peritoneal
dialysis clearances. In fact, recent studies have sug-
gested that alternating hyper- and hypo-osmotic
dialysate solutions may represent a reasonable
approach to enhancing the efficiency of peritoneal
dialysis [15]. The difficulties presented by such an
approach in terms of maintenance of fluid balance
are obvious.
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